Ronald L. Rabin

The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells.

Human B cells become highly responsive to macrophage-inflammatory protein-3 alpha/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding.

The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo.

HIV envelope induces virus expression from resting CD4+ T cells isolated from HIV-infected individuals in the absence of markers of cellular activation or apoptosis.

CXCR3 is induced early on the pathway of CD4+ T cell differentiation and bridges central and peripheral functions.

Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected].

Sample size considerations for establishing clinical bioequivalence of allergen formulations.

Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy.

Characterization of subsets of CD4+ memory T cells reveals early branched pathways of T cell differentiation in humans.

Human T cell cytokine responses are dependent on multidrug resistance protein-1.

HIV regulation of the IL-7R: a viral mechanism for enhancing HIV-1 replication in human macrophages in vitro.

Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus.

Recombinant and modified allergens: the U.S. perspective.

Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3.

Systematic method for determining an ideal housekeeping gene for real-time PCR analysis.

Anaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiologic and biologic disease-modifying antirheumatic drugs.

Regulation of allergenic products in the United States: the promise and problem of adjuvants in allergen immunotherapy.

CCR2 identifies a stable population of human effector memory CD4+ T cells equipped for rapid recall response.

Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells.

Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response.

Low CCR7-mediated migration of human monocyte derived dendritic cells in response to human respiratory syncytial virus and human metapneumovirus.

Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages.

Comments on cow's milk allergy and diphtheria, tetanus, and pertussis vaccines.

TLR9 and TLR7 agonists mediate distinct type I IFN responses in humans and nonhuman primates in vitro and in vivo.

Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent.

The US Food and Drug Administration review of the safety and effectiveness of nonstandardized allergen extracts.

High-throughput quantitative real-time polymerase chain reaction array for absolute and relative quantification of rhesus macaque types I, II, and III interferon and their subtypes.

Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers.

Attenuated expression of interferon-β and interferon-λ1 by human alternatively activated macrophages.

Subtypes of type I IFN differentially enhance cytokine expression by suboptimally stimulated CD4(+) T cells.

Human metapneumovirus SH and G glycoproteins inhibit macropinocytosis-mediated entry into human dendritic cells and reduce CD4+ T cell activation.

Foreword. Allergen products for diagnosis and therapy: regulation and science.

Legal status and regulation of allergenic products in the United States.